These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 28094220)

  • 21. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
    ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.
    Axford LC; Agarwal PK; Anderson KH; Andrau LN; Atherall J; Barker S; Bennett JM; Blair M; Collins I; Czaplewski LG; Davies DT; Gannon CT; Kumar D; Lancett P; Logan A; Lunniss CJ; Mitchell DR; Offermann DA; Palmer JT; Palmer N; Pitt GR; Pommier S; Price D; Narasinga Rao B; Saxena R; Shukla T; Singh AK; Singh M; Srivastava A; Steele C; Stokes NR; Thomaides-Brears HB; Tyndall EM; Watson D; Haydon DJ
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6598-603. PubMed ID: 24239017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of 4,5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors.
    Tomašič T; Mirt M; Barančoková M; Ilaš J; Zidar N; Tammela P; Kikelj D
    Bioorg Med Chem; 2017 Jan; 25(1):338-349. PubMed ID: 27838171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial Evaluation, In Silico Characters and Molecular Docking of Schiff Bases Derived from 5-aminopyrazoles.
    Hassan AS; Askar AA; Nossier ES; Naglah AM; Moustafa GO; Al-Omar MA
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31466322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study.
    Ammar YA; Micky JA; Aboul-Magd DS; Abd El-Hafez SMA; Hessein SA; Ali AM; Ragab A
    Chem Biol Drug Des; 2023 Feb; 101(2):245-270. PubMed ID: 36305722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
    Metwally NH; Abdallah SO; Mohsen MMA
    Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
    Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
    J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.
    Cotman AE; Trampuž M; Brvar M; Kikelj D; Ilaš J; Peterlin-Mašič L; Montalvão S; Tammela P; Frlan R
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28621824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase.
    Zidar N; Tomašič T; Macut H; Sirc A; Brvar M; Montalvão S; Tammela P; Ilaš J; Kikelj D
    Eur J Med Chem; 2016 Jul; 117():197-211. PubMed ID: 27100032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.
    Yule IA; Czaplewski LG; Pommier S; Davies DT; Narramore SK; Fishwick CW
    Eur J Med Chem; 2014 Oct; 86():31-8. PubMed ID: 25137573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors.
    Salem MA; Ragab A; El-Khalafawy A; Makhlouf AH; Askar AA; Ammar YA
    Bioorg Chem; 2020 Mar; 96():103619. PubMed ID: 32036161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates.
    Haiba NS; Khalil HH; Moniem MA; El-Wakil MH; Bekhit AA; Khattab SN
    Bioorg Chem; 2019 Aug; 89():103013. PubMed ID: 31174040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and Docking Studies of Novel Pyrimido[4,5-b]quinolines as Antimicrobial Agents.
    Bakr RB; El Azab IH; Elkanzi NAA
    Chem Biodivers; 2024 Jun; 21(6):e202400200. PubMed ID: 38570192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
    Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA
    Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies.
    Saleh MA; Elmaaty AA; El Saeed HS; Saleh MM; Salah M; Ezz Eldin RR
    Bioorg Chem; 2022 Dec; 129():106186. PubMed ID: 36215786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introducing of novel class of pyrano[2,3-
    Almaghrabi M; Musa A; Aljohani AKB; Ahmed HEA; Alsulaimany M; Miski SF; Mostafa EM; Hussein S; Parambi DGT; Ghoneim MM; Elgammal WE; Halawa AH; Hammad A; El-Agrody AM
    J Biomol Struct Dyn; 2024 Nov; 42(18):9529-9546. PubMed ID: 37661733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docking and 3D QSAR Studies on Substituted Cyclobutylphenyl Quinoline Derivatives as Inhibitors of Bacterial DNA Gyrase.
    Wani RR; Chaudhari HK
    Curr Comput Aided Drug Des; 2018; 14(4):322-337. PubMed ID: 29766821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
    Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
    Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors.
    Nastasă C; Vodnar DC; Ionuţ I; Stana A; Benedec D; Tamaian R; Oniga O; Tiperciuc B
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies.
    Ammar YA; Farag AA; Ali AM; Hessein SA; Askar AA; Fayed EA; Elsisi DM; Ragab A
    Bioorg Chem; 2020 Jun; 99():103841. PubMed ID: 32325335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.